David Edward Clark
29Patents
6h-index
71Co-inventors
72Inventor score
Filing activity: Apr 26, 2000 → Apr 27, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6479519B1 | Substituted anilides | Chemistry; Metallurgy | 52 | Expired |
| US8207187B2 | Use of pyrroloquinoline compounds to kill clinically latent microorganisms | Emerging Cross-Sectional Technologies | 13 | Active |
| US9694006B2 | Use of pyrroloquinoline compounds to kill clinically latent microorganisms | Emerging Cross-Sectional Technologies | 11 | Active |
| US6706738B2 | Substituted bicyclic heteroaryl compounds and their use as integrin antagonists | Chemistry; Metallurgy | 10 | Expired |
| US7326732B2 | EP2 receptor agonists | Chemistry; Metallurgy | 9 | Expired |
| US10493071B2 | Use of pyrroloquinoline compounds to kill clinically latent microorganisms | Emerging Cross-Sectional Technologies | 7 | Active |
| US9266896B2 | Tricyclic compounds and methods of making and using same | Chemistry; Metallurgy | 6 | Active |
| US7803841B2 | EP2 receptor agonists | Chemistry; Metallurgy | 6 | Active |
| US7417068B2 | EP4 receptor antagonists | Human Necessities | 5 | Expired |
| US7196089B2 | EP4 receptor antagonists | Chemistry; Metallurgy | 5 | Expired |
| US7569602B2 | Furan derivatives as EP4 receptor antagonists | Human Necessities | 4 | Expired |
| US6562851B2 | Substituted bicyclic compounds | Chemistry; Metallurgy | 3 | Expired |
| US8080567B2 | EP2 receptor agonists | Chemistry; Metallurgy | 2 | Active |
| US7528157B2 | EP4 receptor antagonists | Chemistry; Metallurgy | 2 | Active |
| US7662839B2 | EP2 receptor agonists | Chemistry; Metallurgy | 2 | Active |
| US6593354B2 | Substituted benzoxazole compounds | Chemistry; Metallurgy | 2 | Expired |
| US7507754B2 | EP4 receptor antagonists | Chemistry; Metallurgy | 2 | Active |
| US11000511B2 | Chemical compounds as antibiotics | Chemistry; Metallurgy | 1 | Active |
| US11613527B2 | Enzyme inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10005773B2 | 1-(4-pyrimidinyl)-1H-pyrrolo[3,2-c]pyridine derivatives as NIK inhibitors | Human Necessities | 0 | Active |
| US12286411B2 | Indane derivatives for use in the treatment of bacterial infection | Chemistry; Metallurgy | 0 | Active |
| US10954236B2 | Tyrosine amide derivatives as Rho-Kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9981963B2 | 3-(1H-pyrazol-4-yl)-1H-pyrrolo[2,3-c]pyridine derivatives as NIK inhibitors | Chemistry; Metallurgy | 0 | Active |
| US12247013B2 | Indane derivatives for use in the treatment of bacterial infection | Chemistry; Metallurgy | 0 | Active |
| US10501461B2 | Tyrosine amide derivatives as Rho-kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.